A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL
Clinical trial NCT02514083 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02514083
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-09
- Primary completion
- 2019-10-02
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.